Since 2006, Sound Analytics has partnered with SCIEX to develop DiscoveryQuant, revolutionizing Drug Discovery.

Introduced in 2014, DiscoveryQuant 3.0 expands on the proven ADME software that enables scientists to significantly reduce LC/MS method development and optimization time for high throughput drug discovery (ADME) laboratories focusing on both small molecules and biotherapeutics. Scientists can now make better decisions about drug candidates faster, as DiscoveryQuant 3.0 software reduces tedious LC/MS method development time with a fast, robust, and reliable process that optimizes methods for hundreds of small and/or large molecules.

DiscoveryQuant 3.0 Software expedites the method development process from existing database information, automates on-column optimization, and easily analyzes and processes multiple samples at the same time. Supported on all AB SCIEX MS platforms (TripleTOF®, QTRAP®, and Triple Quad™ systems) and with the ability to seamlessly communicate with MultiQuant™ 3.0 Software, DiscoveryQuant 3.0 Software ensures success in high throughput drug discovery and development.